SEC INSIDER TRANSACTIONS

QUALCOMM INC/DE (QCOM) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

QCOM · QUALCOMM INC/DE

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 38 filings · fetched 2026-11-13T19:39:12Z

Recent reported activity

0purchase rows on this page

14sale rows on this page

136matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-09-11Filed 2026-09-11	Palkhiwala Akash J.Officer · EVP, CFO & COO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. F2 The sale prices for this transaction ranged from $177.3150 to $178.1200. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F3 The sale prices for this transaction ranged from $178.4400 to $179.0125. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F4 The sale prices for this transaction ranged from $179.4675 to $180.2200. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F5 The sale prices for this transaction ranged from $180.4400 to $181.2800. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F6 The sale prices for this transaction ranged from $181.3550 to $182.3100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F7 The sale prices for this transaction ranged from $182.3525 to $183.2100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F8 The sale prices for this transaction ranged from $183.3800 to $184.2450. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F9 The sale prices for this transaction ranged from $184.3150 to $185.2100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. References: F1, F7	S Sale (market/private)Common Stock · Non-derivative	508D	182.6937	Direct	Form 4 ↗0000804328-26-000094
2026-09-11Filed 2026-09-11	Palkhiwala Akash J.Officer · EVP, CFO & COO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. F2 The sale prices for this transaction ranged from $177.3150 to $178.1200. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F3 The sale prices for this transaction ranged from $178.4400 to $179.0125. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F4 The sale prices for this transaction ranged from $179.4675 to $180.2200. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F5 The sale prices for this transaction ranged from $180.4400 to $181.2800. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F6 The sale prices for this transaction ranged from $181.3550 to $182.3100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F7 The sale prices for this transaction ranged from $182.3525 to $183.2100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F8 The sale prices for this transaction ranged from $183.3800 to $184.2450. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F9 The sale prices for this transaction ranged from $184.3150 to $185.2100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. References: F1, F6	S Sale (market/private)Common Stock · Non-derivative	696D	181.8905	Direct	Form 4 ↗0000804328-26-000094
2026-09-11Filed 2026-09-11	Palkhiwala Akash J.Officer · EVP, CFO & COO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. F2 The sale prices for this transaction ranged from $177.3150 to $178.1200. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F3 The sale prices for this transaction ranged from $178.4400 to $179.0125. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F4 The sale prices for this transaction ranged from $179.4675 to $180.2200. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F5 The sale prices for this transaction ranged from $180.4400 to $181.2800. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F6 The sale prices for this transaction ranged from $181.3550 to $182.3100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F7 The sale prices for this transaction ranged from $182.3525 to $183.2100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F8 The sale prices for this transaction ranged from $183.3800 to $184.2450. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F9 The sale prices for this transaction ranged from $184.3150 to $185.2100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. References: F1, F5	S Sale (market/private)Common Stock · Non-derivative	82D	180.8706	Direct	Form 4 ↗0000804328-26-000094
2026-09-11Filed 2026-09-11	Palkhiwala Akash J.Officer · EVP, CFO & COO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. F2 The sale prices for this transaction ranged from $177.3150 to $178.1200. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F3 The sale prices for this transaction ranged from $178.4400 to $179.0125. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F4 The sale prices for this transaction ranged from $179.4675 to $180.2200. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F5 The sale prices for this transaction ranged from $180.4400 to $181.2800. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F6 The sale prices for this transaction ranged from $181.3550 to $182.3100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F7 The sale prices for this transaction ranged from $182.3525 to $183.2100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F8 The sale prices for this transaction ranged from $183.3800 to $184.2450. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F9 The sale prices for this transaction ranged from $184.3150 to $185.2100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. References: F1, F4	S Sale (market/private)Common Stock · Non-derivative	48D	179.7613	Direct	Form 4 ↗0000804328-26-000094
2026-09-11Filed 2026-09-11	Palkhiwala Akash J.Officer · EVP, CFO & COO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. F2 The sale prices for this transaction ranged from $177.3150 to $178.1200. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F3 The sale prices for this transaction ranged from $178.4400 to $179.0125. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F4 The sale prices for this transaction ranged from $179.4675 to $180.2200. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F5 The sale prices for this transaction ranged from $180.4400 to $181.2800. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F6 The sale prices for this transaction ranged from $181.3550 to $182.3100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F7 The sale prices for this transaction ranged from $182.3525 to $183.2100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F8 The sale prices for this transaction ranged from $183.3800 to $184.2450. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F9 The sale prices for this transaction ranged from $184.3150 to $185.2100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. References: F1, F3	S Sale (market/private)Common Stock · Non-derivative	36D	178.6308	Direct	Form 4 ↗0000804328-26-000094
2026-09-11Filed 2026-09-11	Palkhiwala Akash J.Officer · EVP, CFO & COO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. F2 The sale prices for this transaction ranged from $177.3150 to $178.1200. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F3 The sale prices for this transaction ranged from $178.4400 to $179.0125. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F4 The sale prices for this transaction ranged from $179.4675 to $180.2200. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F5 The sale prices for this transaction ranged from $180.4400 to $181.2800. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F6 The sale prices for this transaction ranged from $181.3550 to $182.3100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F7 The sale prices for this transaction ranged from $182.3525 to $183.2100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F8 The sale prices for this transaction ranged from $183.3800 to $184.2450. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F9 The sale prices for this transaction ranged from $184.3150 to $185.2100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	32D	177.6169	Direct	Form 4 ↗0000804328-26-000094
2026-08-31Filed 2026-08-31	Grech Patricia YOfficer · SVP, Chief Accounting Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2025. F2 Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	208D	170	Indirectby Trust	Form 4 ↗0000804328-26-000093
2026-08-21Filed 2026-08-21	Grech Patricia YOfficer · SVP, Chief Accounting Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2025. F3 Each Restricted Stock Unit is the economic equivalent of one share of Qualcomm common stock and converts on a one-for-one basis. F4 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2024 and ending on November 20, 2026. F5 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2025 and ending on November 20, 2027. F6 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2027. F7 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2028. References: F2, F1	S Sale (market/private)Common Stock · Non-derivative	625D	162.85	Indirectby Trust	Form 4 ↗0000804328-26-000092
2026-08-20Filed 2026-08-21	Grech Patricia YOfficer · SVP, Chief Accounting Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2025. F3 Each Restricted Stock Unit is the economic equivalent of one share of Qualcomm common stock and converts on a one-for-one basis. F4 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2024 and ending on November 20, 2026. F5 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2025 and ending on November 20, 2027. F6 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2027. F7 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2028. References: F3, F7	M Exercise / conversionRestricted Stock Unit · Derivative	44.7262D	0	Direct	Form 4 ↗0000804328-26-000092
2026-08-20Filed 2026-08-21	Grech Patricia YOfficer · SVP, Chief Accounting Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2025. F3 Each Restricted Stock Unit is the economic equivalent of one share of Qualcomm common stock and converts on a one-for-one basis. F4 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2024 and ending on November 20, 2026. F5 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2025 and ending on November 20, 2027. F6 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2027. F7 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2028. References: F3, F7	M Exercise / conversionRestricted Stock Unit · Derivative	316.1332D	0	Direct	Form 4 ↗0000804328-26-000092
2026-08-20Filed 2026-08-21	Grech Patricia YOfficer · SVP, Chief Accounting Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2025. F3 Each Restricted Stock Unit is the economic equivalent of one share of Qualcomm common stock and converts on a one-for-one basis. F4 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2024 and ending on November 20, 2026. F5 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2025 and ending on November 20, 2027. F6 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2027. F7 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2028. References: F3, F6	M Exercise / conversionRestricted Stock Unit · Derivative	171.7895D	0	Direct	Form 4 ↗0000804328-26-000092
2026-08-20Filed 2026-08-21	Grech Patricia YOfficer · SVP, Chief Accounting Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2025. F3 Each Restricted Stock Unit is the economic equivalent of one share of Qualcomm common stock and converts on a one-for-one basis. F4 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2024 and ending on November 20, 2026. F5 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2025 and ending on November 20, 2027. F6 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2027. F7 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2028. References: F3, F5	M Exercise / conversionRestricted Stock Unit · Derivative	316.8809D	0	Direct	Form 4 ↗0000804328-26-000092
2026-08-20Filed 2026-08-21	Grech Patricia YOfficer · SVP, Chief Accounting Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2025. F3 Each Restricted Stock Unit is the economic equivalent of one share of Qualcomm common stock and converts on a one-for-one basis. F4 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2024 and ending on November 20, 2026. F5 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2025 and ending on November 20, 2027. F6 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2027. F7 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2028. References: F3, F4	M Exercise / conversionRestricted Stock Unit · Derivative	427.8561D	0	Direct	Form 4 ↗0000804328-26-000092
2026-08-20Filed 2026-08-21	Grech Patricia YOfficer · SVP, Chief Accounting Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2025. F3 Each Restricted Stock Unit is the economic equivalent of one share of Qualcomm common stock and converts on a one-for-one basis. F4 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2024 and ending on November 20, 2026. F5 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2025 and ending on November 20, 2027. F6 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2027. F7 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2028. References: F1	F WithholdingCommon Stock · Non-derivative	441D	160.74	Indirectby Trust	Form 4 ↗0000804328-26-000092
2026-08-20Filed 2026-08-21	Grech Patricia YOfficer · SVP, Chief Accounting Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2025. F3 Each Restricted Stock Unit is the economic equivalent of one share of Qualcomm common stock and converts on a one-for-one basis. F4 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2024 and ending on November 20, 2026. F5 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2025 and ending on November 20, 2027. F6 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2027. F7 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2028. References: F1	M Exercise / conversionCommon Stock · Non-derivative	44A	0	Indirectby Trust	Form 4 ↗0000804328-26-000092
2026-08-20Filed 2026-08-21	Grech Patricia YOfficer · SVP, Chief Accounting Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2025. F3 Each Restricted Stock Unit is the economic equivalent of one share of Qualcomm common stock and converts on a one-for-one basis. F4 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2024 and ending on November 20, 2026. F5 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2025 and ending on November 20, 2027. F6 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2027. F7 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2028. References: F1	M Exercise / conversionCommon Stock · Non-derivative	171A	0	Indirectby Trust	Form 4 ↗0000804328-26-000092
2026-08-20Filed 2026-08-21	Grech Patricia YOfficer · SVP, Chief Accounting Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2025. F3 Each Restricted Stock Unit is the economic equivalent of one share of Qualcomm common stock and converts on a one-for-one basis. F4 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2024 and ending on November 20, 2026. F5 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2025 and ending on November 20, 2027. F6 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2027. F7 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2028. References: F1	M Exercise / conversionCommon Stock · Non-derivative	316A	0	Indirectby Trust	Form 4 ↗0000804328-26-000092
2026-08-20Filed 2026-08-21	Grech Patricia YOfficer · SVP, Chief Accounting Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2025. F3 Each Restricted Stock Unit is the economic equivalent of one share of Qualcomm common stock and converts on a one-for-one basis. F4 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2024 and ending on November 20, 2026. F5 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2025 and ending on November 20, 2027. F6 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2027. F7 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2028. References: F1	M Exercise / conversionCommon Stock · Non-derivative	316A	0	Indirectby Trust	Form 4 ↗0000804328-26-000092
2026-08-20Filed 2026-08-21	Grech Patricia YOfficer · SVP, Chief Accounting Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2025. F3 Each Restricted Stock Unit is the economic equivalent of one share of Qualcomm common stock and converts on a one-for-one basis. F4 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2024 and ending on November 20, 2026. F5 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2025 and ending on November 20, 2027. F6 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2027. F7 The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2028. References: F1	M Exercise / conversionCommon Stock · Non-derivative	427A	0	Indirectby Trust	Form 4 ↗0000804328-26-000092
2026-08-12Filed 2026-08-12	Palkhiwala Akash J.Officer · EVP, CFO & COO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. F2 The sale prices for this transaction ranged from $161.1150 to $162.1000. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F3 The sale prices for this transaction ranged from $162.1350 to $163.1075. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F4 The sale prices for this transaction ranged from $163.1150 to $164.0600. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F5 The sale prices for this transaction ranged from $164.1350 to $165.0850. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F6 The sale prices for this transaction ranged from $165.1175 to $165.7100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. References: F1, F6	S Sale (market/private)Common Stock · Non-derivative	164D	165.3368	Direct	Form 4 ↗0000804328-26-000091
2026-08-12Filed 2026-08-12	Palkhiwala Akash J.Officer · EVP, CFO & COO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. F2 The sale prices for this transaction ranged from $161.1150 to $162.1000. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F3 The sale prices for this transaction ranged from $162.1350 to $163.1075. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F4 The sale prices for this transaction ranged from $163.1150 to $164.0600. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F5 The sale prices for this transaction ranged from $164.1350 to $165.0850. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F6 The sale prices for this transaction ranged from $165.1175 to $165.7100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. References: F1, F5	S Sale (market/private)Common Stock · Non-derivative	248D	164.7277	Direct	Form 4 ↗0000804328-26-000091
2026-08-12Filed 2026-08-12	Palkhiwala Akash J.Officer · EVP, CFO & COO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. F2 The sale prices for this transaction ranged from $161.1150 to $162.1000. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F3 The sale prices for this transaction ranged from $162.1350 to $163.1075. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F4 The sale prices for this transaction ranged from $163.1150 to $164.0600. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F5 The sale prices for this transaction ranged from $164.1350 to $165.0850. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F6 The sale prices for this transaction ranged from $165.1175 to $165.7100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. References: F1, F4	S Sale (market/private)Common Stock · Non-derivative	1,080D	163.4452	Direct	Form 4 ↗0000804328-26-000091
2026-08-12Filed 2026-08-12	Palkhiwala Akash J.Officer · EVP, CFO & COO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. F2 The sale prices for this transaction ranged from $161.1150 to $162.1000. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F3 The sale prices for this transaction ranged from $162.1350 to $163.1075. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F4 The sale prices for this transaction ranged from $163.1150 to $164.0600. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F5 The sale prices for this transaction ranged from $164.1350 to $165.0850. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F6 The sale prices for this transaction ranged from $165.1175 to $165.7100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. References: F1, F3	S Sale (market/private)Common Stock · Non-derivative	748D	162.5579	Direct	Form 4 ↗0000804328-26-000091
2026-08-12Filed 2026-08-12	Palkhiwala Akash J.Officer · EVP, CFO & COO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. F2 The sale prices for this transaction ranged from $161.1150 to $162.1000. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F3 The sale prices for this transaction ranged from $162.1350 to $163.1075. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F4 The sale prices for this transaction ranged from $163.1150 to $164.0600. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F5 The sale prices for this transaction ranged from $164.1350 to $165.0850. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. F6 The sale prices for this transaction ranged from $165.1175 to $165.7100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	260D	161.7729	Direct	Form 4 ↗0000804328-26-000091
2026-08-03Filed 2026-08-03	ACE HEATHER SOfficer · EVP, Chief HR Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on September 11, 2025. F2 Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	3,200D	147.04	Indirectby Trust	Form 4 ↗0000804328-26-000090

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.